Clinical Trial Update: An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression [Phase 2]

View source ↗

Summary

Open-label Phase 2 study to evaluate the safety, tolerability, and pharmacodynamics of BPL-003 in patients with treatment-resistant depression; currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• BPL-003

Snippet

Sponsor: Beckley Psytech Limited | Conditions: Treatment Resistant Depression | Phase 2 | Status: RECRUITING